Enhancing Therapeutic Approaches in Glioblastoma with Pro-Oxidant Treatments and Synergistic Combinations: In Vitro Experience of Doxorubicin and Photodynamic Therapy.

Int J Mol Sci · 2024 · PMC11277534 · PMID 39062770

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

A clear trend emerged with U87MG showing the highest sensitivity (IC50 of 0.14 ± 0.1 μM) and LN229 exhibiting the greatest resistance (IC50 of 6.88 ± 0.6 μM).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.